North America Lyophilized Injectable Drugs Market, By Packaging (Vials, Dual-Chamber Syringes, Dual-Chamber Cartridges and Others), Drug Class (Anti-Infective, Antineoplastic, Diuretics, Proton Pump Inhibitor, Anesthetic, Anticoagulant, NSAID’s, Corticosteroids and Others), Form (Powder and Liquid), Indication (Oncology, Autoimmune Diseases, Hormonal Disorders, Respiratory Diseases, Gastrointestinal Disorders, Dermatological Disorders, Ophthalmic Diseases and Others), Route of Administration (Intravenous/Infusion, Intramuscular and Others), End User (Hospital, Clinics, Home Healthcare and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2028.
Market Analysis and Insights: North America Lyophilized Injectable Drugs Market
The North America lyophilized injectable drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.7% in the forecast period of 2021 to 2028 and is expected to reach USD 3,283.61 million by 2028. Increase in chronic health conditions across the globe is expected to act as a driver for boosting the demand of the lyophilized injectable drugs market.
Freeze-drying is another term for lyophilization. It is a technique of isolating a solid material from a solvent by freezing and evaporating the solution under vacuum. Lyophilized products are considered to have a longer shelf life than conventional medications and are thus favoured. The protection of biologics, proteins, antibodies microorganisms, parenteral, blood plasma, enzymes, diagnostic reagents, vaccines and nutraceuticals are usually done through lyophilization. To keep some unstable bulk ingredients stable, lyophilization of the sterile injectable is needed.
Growing technological advancement of the lyophilized injectable drugs is expected to act as a driver for boosting the demand of the lyophilized injectable drugs market. Rise in number of product recalls for lyophilized drugs and packaging type is expected to act as restraint of the lyophilized injectable drugs market. Rise in regulatory approvals for lyophilized drugs is expected to act as an opportunity for boosting the demand of the lyophilized injectable drugs market. The factors associated with manufacturing lyophilized vials for parenteral products are expected to challenge the demand for the lyophilized injectable drugs market.
The lyophilized injectable drugs market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the lyophilized injectable drugs market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
North America Lyophilized Injectable Drugs Market scope and market size
The North America lyophilized injectable drugs market is categorized into seven notable segments which are based on the packaging, drug class, form, indication, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of packaging, the lyophilized injectable drugs market is segmented into vials, dual-chamber syringes, dual-chamber cartridges and others. In 2021, vials segment is expected to dominate the lyophilized injectable drugs market because the vials are most cost effective than other packaging.
- On the basis of drug class, the lyophilized injectable drugs market is segmented into anti-infective, antineoplastic, diuretics, proton pump inhibitor, anesthetic, anticoagulant, NSAID’s, corticosteroids and others. In 2021, anti-infective segment is expected to dominate the lyophilized injectable drugs market because of the increased demand for the as anti-infective consists of various antibiotics which helps in preventing infection after the surgery.
- On the basis of form, the lyophilized injectable drugs market is segmented into powder and liquid. In 2021, powder segment is expected to dominate the lyophilized injectable drugs market because of it is easy to transport and the chances of microbial growth are very less.
- On the basis of indication, the lyophilized injectable drugs market is segmented into oncology, autoimmune diseases, hormonal disorders, respiratory diseases, gastrointestinal disorders, dermatological disorders, ophthalmic diseases and others. In 2021, oncology segment is expected to dominate the lyophilized injectable drugs market because of this disease is more and the R&D is more focused on developing drugs that are used for oncology.
- On the basis of route of administration, the lyophilized injectable drugs market is segmented into intravenous/infusion, intramuscular and others. In 2021, intravenous/infusion segment is expected to dominate the lyophilized injectable drugs market because of the delivery rate is very high even the volume of the drug is very less.
- On the basis of end user, the lyophilized injectable drugs market is segmented into hospital, clinics, home healthcare and others. In 2021, hospital segment is expected to dominate the lyophilized injectable drugs market due to the funds that are provided to these facilities to take more lyophilised drugs as compared to other end users.
- On the basis of distribution channel, the lyophilized injectable drugs market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is expected to dominate the lyophilized injectable drugs market because the key players are mostly tie bonds with these dealers to distribute there drugs.
Lyophilized Injectable Drugs Market Country Level Analysis
North America lyophilized injectable drugs market is analysed and market size information is provided by the country, packaging, drug class, form, indication, route of administration, end user and distribution channel as referenced above.
The countries covered in the North America lyophilized injectable drugs market are U.S., Canada and Mexico.
- In North America, U.S. is expected to dominate the lyophilized injectable drugs market because of increasing demand of lyophilised drugs due to increasing in disease like cancer.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
New product launches by manufactures is Creating New Opportunities for Players in the Lyophilized Injectable Drugs Market
Lyophilized injectable drugs market also provides you with detailed market analysis for every country growth in aesthetic industry with Lyophilized Injectable Drugs Market sales, impact of advancement in the lyophilized injectable drugs market and changes in regulatory scenarios with their support for the market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Lyophilized Injectable Drugs Market Share Analysis
Lyophilized injectable drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the lyophilized injectable drugs market.
The major companies providing lyophilized injectable drugs in the North America lyophilized injectable drugs market are AuroMedics Pharma LLC Pharma LLC (a subsidiary of Aurobindo Pharma), Astellas Pharma US, Inc. (a subsidiary of Astellas Pharma Inc.), Aristopharma Ltd., Pfizer Inc., Viatris Inc., Gilead Sciences, Inc., Cirondrugs, Amneal Pharmaceuticals LLC, Jubilant Generics Limited – A Jubilant Pharma Company, Novartis AG, Otsuka America Pharmaceutical, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Fresenius Kabi USA (a subsidiary of Fresenius Kabi AG), Sanofi, Celon Laboratories Pvt. Ltd. and Baxter among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the lyophilized injectable drugs market.
For instance,
- In November 2019, Novartis AG announced that it has undergone a strategic agreement with the Medicines Company, the U.S. based pharmaceutical companies. This agreement done by the company has strengthened its innovative medicine product portfolio leading to increased sales and revenue in the market.
- In March 2021, Zydus Cadila announced that it has reduced the cost of its drug Remdac, a generic version of Remdesivir used for the COVID-19 patients in India. This strategic initiative taken by the company has increased its demand and sales in the market leading to increased credibility of the company.
This new product launched by the company has increased its protein estimation portfolio in the market. Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the lyophilized injectable drugs market which also provides the benefit for organisation to improve their offering for the market.
SKU-